DURECT Corporation (DRRX)
Symbol Info
Listed Symbol DRRX
Name DURECT Corporation
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $18,564,000
Latest Fiscal EPS $-0.16
Price Info
21 Day Moving Average $1.9062
21 Day EMA $1.825480
50 Day Moving Average $1.6834
50 Day EMA $1.642030
200 Day EMA $1.166460
200 Day Moving Average 0.922130
52 Week High $2.46
52 Week Low $0.46
52 Week Change $77.083300
Alpha 0.034715
Beta 1.7825
Standard Deviation 0.268777
R2 0.051924
Periods 60
Share Information
10 Day Average Volume 792,527
20 Day Average Volume 1,111,824
30 Day Average Volume 985,955
50 Day Average Volume 974,804
Outstanding Shares 191,942,234
Float Shares 186,566,519
Percent Float 97.20%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 162
Institute Holdings Date 2019-09-30
Institute Bought Previous 3 Months 9,581,933
Institute Holdings Percent 49.900000
Institute Sold Previous 3 Months 22,571,563
Insider Holdings Date 2019-08-31
Insider Bought Previous 3 Months 25
Insider Holdings Percent 2.80%
Insider Sold Previous 3 Months -
Insiders Shares Owned 5,375,715
Price Change
7 Day Price Change $-0.17
7 Day Percent Change -9.09%
21 Day Price Change $-0.4400001
21 Day Percent Change -20.56%
30 Day Price Change $-0.02
30 Day Percent Change -1.16%
Month To Date Price Change $-0.14
Month To Date Percent -7.61%
90 Day Price Change $1.042600
90 Day Percent Change 158.59%
Quarter To Date $-0.14
Quarter To Date Percent -7.61%
180 Day Price Change $1.030000
180 Day Percent Change 153.73%
200 Day Price Change $1.017800
200 Day Percent Change 149.19%
Year To Date $1.216900
Year To Date Percent 251.89%
Profile
Description Durect Corp is a biopharmaceutical company. It is engaged in the research, development and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and drug delivery programs. The company's pipeline products consist of DUR-928, RBP-7000, Remoxy, POSIMIR, and others.
Details
Issue Type CS
Market Cap $326,301,798
Sec Type EQS
Auditor Ernst & Young LLP
Total Shares Outstanding 191,942,234
CEO James E. Brown
Employees 85
Last Audit UQ
Classification
CIK 0001082038
Industry Drug Manufacturers
Sector Healthcare
NAICS Pharmaceutical Preparation Manufacturing(325412)
Info
Address 10260 Bubb Road
Cupertino, CA 95014-4166
Website http://www.durect.com
Facisimile +1 408 777-3577
Telephone +1 408 777-1417
Email mike.arenberg@durect.com
Key Ratios
Profitability
EBIT Margin -110.2
EBITDA Margin -109.3
Pre-Tax Profit Margin -124.5
Profit Margin Cont -
Gross Margin 79.70
Profit Margin TOT -
Income Statements
Revenue $11,743,000
Revenue Per Share $0.0612
Revenue 3 Years $-0.14
Revenue 5 Years $0.54
Valuation Measures
PE Ratio -
Enterprise Value $343,201,710
Price To Sales 27.786922
Price To Free Cash -19.3
PE High Last 5 Years -
Price To Book 15.1
Price To Cash Flow 200.6
PE Low Last 5 Years -
Price To Tangible Book 21.0
Financial Strength
Total Debt To Equity 1.2
Int Coverage -8.5
Current Ratio 4.3
Leverage Ratio 3.4
Quick Ratio 3.8
Long Term Debt To Capital 0.52
Assets
Receivables Turnover 2.5
Invoice Turnover 1.10
Assets Turnover 0.10
Management Effectiveness
Return Assets -41.52
Return On Equity -95.27
Return On Capital -45.78
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
DRRX
Durect
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.